Cargando…
Computational screening of FDA-approved drugs to identify potential TgDHFR, TgPRS, and TgCDPK1 proteins inhibitors against Toxoplasma gondii
Toxoplasma gondii (T. gondii) is one of the most successful parasites in the world, because about a third of the world's population is seropositive for toxoplasmosis. Treatment regimens for toxoplasmosis have remained unchanged for the past 20 years, and no new drugs have been introduced to the...
Autores principales: | Gharibi, Zahra, Shahbazi, Behzad, Gouklani, Hamed, Nassira, Hoda, Rezaei, Zahra, Ahmadi, Khadijeh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10070243/ https://www.ncbi.nlm.nih.gov/pubmed/37012275 http://dx.doi.org/10.1038/s41598-023-32388-9 |
Ejemplares similares
-
Immunization With a DNA Vaccine Cocktail Encoding TgPF, TgROP16, TgROP18, TgMIC6, and TgCDPK3 Genes Protects Mice Against Chronic Toxoplasmosis
por: Zhang, Nian-Zhang, et al.
Publicado: (2018) -
TgCDPK3 Regulates Calcium-Dependent Egress of Toxoplasma gondii from Host Cells
por: McCoy, James M., et al.
Publicado: (2012) -
Protein kinase TgCDPK7 regulates vesicular trafficking and phospholipid synthesis in Toxoplasma gondii
por: Bansal, Priyanka, et al.
Publicado: (2021) -
Correction: TgCDPK3 Regulates Calcium-Dependent Egress of Toxoplasma gondii from Host Cells
por: McCoy, James M., et al.
Publicado: (2013) -
Phosphorylation of a Myosin Motor by TgCDPK3 Facilitates Rapid Initiation of Motility during Toxoplasma gondii egress
por: Gaji, Rajshekhar Y., et al.
Publicado: (2015)